QIAGEN is the leading provider of sample and assay technologies. Sample technologies are used to isolate DNA, RNA and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.
We have developed more than 500 consumable products and automated solutions. We are the market leader in academic research markets, to leading pharmaceutical and biotechnology companies, to molecular diagnostics laboratories as well as applied testing markets such as forensics, animal or food testing, and pharmaceutical process control.
QIAGEN employs more than 3,900 people in over 35 locations worldwide.
QIAGEN公司在全球35個國家，有著超過3900名員工和一支國際化的管理隊伍。行業(yè)領(lǐng)先的技術(shù)使我們在未來能夠持續(xù)成長和保持領(lǐng)先地位。
我們致力于全球生物技術(shù)市場。我們有著全球網(wǎng)絡(luò)，代理商服務(wù)國家超過42個。同客戶的緊密聯(lián)系使得我們能夠不斷保持處于技術(shù)前沿，不斷滿足市場需求，不斷完善我們產(chǎn)品發(fā)展系統(tǒng)。
從1986年以來，我們已經(jīng)完善和上市了許多科研產(chǎn)品和工業(yè)的產(chǎn)品，應(yīng)用于核酸純化技術(shù)等方面，如：生命科學(xué)研究，基因組研究，基因藥物發(fā)現(xiàn)，核酸分子診斷，基因疫苗和基因治療市場等。核酸純化市場的快速發(fā)展促使我們不斷完善核酸純化技術(shù)。